[Fluorescence polarization for measuring the production of surfactant in pathological pregnancies].
D000653:Amniotic Fluid / Q000032:analysis*; D005260:Female; D005317:Fetal Growth Retardation / Q000378:metabolism; D005322:Premature Rupture of Fetal Membranes / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000378:metabolism; D007231:Infant, Newborn; D008168:Lung / Q000254:growth & development; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism*; D011249:Pregnancy Complications, Cardiovascular / Q000378:metabolism; D011254:Pregnancy in Diabetics / Q000378:metabolism; D011663:Pulmonary Surfactants / Q000032:analysis*; D012127:Respiratory Distress Syndrome, Newborn / Q000503:physiopathology*; D012203:Rh Isoimmunization / Q000378:metabolism; D012306:Risk
D011663:Pulmonary Surfactants
La polarizzazione a fluorescenza per la misurazione della produzione di surfattante in gravidanze patologiche.